CLSM was used to GANT61 cost create three-dimensional reconstructions of the PAO1 biofilms. NAC at 1 mg/ml, 2.5 mg/ml and 5 mg/ml significantly decreased the fluorescence of PAO1 biofilms after 24 hours exposure compared with control (P < 0.01). When analyzed using COMSTAT software, P. aeruginosa biofilms showed significant structural differences in the presence of the NAC regimen (Table 1). The biomass, substratum coverage, average thickness, maximum thickness and surface area of the biomass all decreased for

biofilms grown in the presence of NAC. The surface to this website volume ratio and roughness coefficients showed the opposite trends. Table 1 Effects of NAC (mg/ml) on biofilm structures of PAO1 Features control NAC 0.5 NAC

buy LDN-193189 1 NAC 2.5 NAC 5 Biomass (μm3/μm2) 2.79 ± 0.64 1.63* ± 0.46 0.98* ± 0.57 0.34* ± 0.17 0.23* ± 0.12 Substratum coverage 0.52 ± 0.19 0.34 ± 0.11 0.35 ± 0.19 0.20* ± 0.08 0.21* ± 0.11 Average thickness (μm) 2.70 ± 0.80 1.47* ± 0.47 0.75* ± 0.51 0.19* ± 0.16 0.01* ± 0.01 Maximum thickness (μm) 10.20 ± 1.64 8.40* ± 1.92 5.20* ± 1.64 3.00* ± 0.80 1.60* ± 0.48 Surface area of biomass (μm2) 162515.9 ± 27990.3 99499.0* ± 25130.4 102665.0* ± 50400.6 49869.1* ± 24393.6 41504.3* ± 18129.7 Surface to volume ratio (μm2/μm3) 1.39 ± 0.33 1.41 ± 0.12 2.66* ± 0.56 3.64* ± 0.78 4.47* ± 0.66 Roughness coefficient 1.12 ± 0.19 1.43 ± 0.14 1.53* ± 0.27 1.72* ± 0.25 1.97* ± 0.02 Note: n = 10 image stacks, *compared with control, P < 0.01 Viable cell counts after treatment with NAC combined with CIP Results for viable cell counts in biofilms are shown in Table 2. NAC had an independent anti-microbial effect on biofilm-associated P. aeruginosa at 2.5 mg/ml (p < 0.01). Compared with the control,

there were significant differences at ciprofloxacin (CIP) of 2 MIC, 4 MIC or 8 MIC (p < 0.01). NAC-ciprofloxacin Oxaprozin combinations consistently decreased viable biofilm-associated bacterial counts relative to the control. This combination was synergistic at NAC of 0.5 mg/ml and CIP of 1/2MIC (p < 0.01). Table 2 Viable counts of P. aeruginosa biofilm bacteria treated with NAC combined with ciprofloxacin (lg [CFU/cm2]) NAC (mg/ml) ciprofloxacin (MIC)   0 1/2 1 2 4 8 0 7.11 ± 0.34 6.96 ± 0.34 6.95 ± 0.31 6.84 ± 0.32 6.76 ± 0.29 6.60 ± 0.30 0.5 6.97 ± 0.31 6.70 ± 0.31 6.65* ± 0.33 6.40* ± 0.46 6.37* ± 0.33 6.06* ± 0.48 1 6.87 ± 0.34 6.58* ± 0.26 6.47* ± 0.33 6.23* ± 0.37 5.94* ± 0.56 5.62* ± 0.59 2.5 6.45* ± 0.27 6.22* ± 0.25 6.15* ± 0.26 6.03* ± 0.35 5.76* ± 0.58 5.05* ± 0.35 Note: n = 20 strains, *compared with NAC at 0 mg/ml and the same concentration of ciprofloxacin, P < 0.01 Effect of NAC on extracellular polysaccharides (EPS) production EPS production by P.